Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.
Autor: | Patrikidou, Anna1, Domont, Julien1, Chabaud, Sylvie2, Ray-Coquard, Isabelle2, Coindre, Jean-Michel3, Bui-Nguyen, Binh3, Adenis, Antoine4, Rios, Maria5, Bertucci, François6, Duffaud, Florence7, Chevreau, Christine8, Cupissol, Didier9, Pérol, David2, Emile, Jean-François10, Blay, Jean-Yves11, Cesne, Axel Le1 Axel.LECESNE@gustaveroussy.fr |
---|---|
Zdroj: | European Journal of Cancer. Jan2016, Vol. 52, p173-180. 8p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |